Senator finds GSK profited by pulling kids’ asthma inhaler

In 2024, doctors and parents scrambled to find an affordable asthma inhaler after drugmaker GSK pulled the popular Flovent off the market. A senator launched an investigation to find out what happened, sharing her findings exclusively with CNN. #news #cnn